1 completed, 1 terminated, 1 unknown. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Choroidal Neovascular Membrane: new trials by email Literature Review of Choroidal Neovascular Membrane trials Research Report on Choroidal Neovascular Membrane
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anti-VEGF in Real-world Ranibizumab, Aflibercept, Conbercept - Neovascular Age-related Macular Edema, Diabetic Macular Edema | Unknown | Wenbin Wei | 1000 | 2022-01-01 | 2022-02-03 | |
| Optic Nerve and Retinal Functions With Bevacizumab Electrophysiology - Choroidal Neovascular Membrane | Completed | Cairo University | 45 | 2010-01-01 | 2011-05-27 | |
| A Study of Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial) Ranibizumab - Age Related Macular Degeneration, Choroidal Neovascular Membrane | Phase 1 / Phase 2 | Terminated | David M. Brown, M.D. | 88 | 2009-12-01 | 2017-01-02 |
Eye Diseases (1) · Macular Degeneration (1) · Retinal Degeneration (1) · Retinal Diseases (1) · Retinal Vein Occlusion (1)
Cardiovascular Diseases (1) · Embolism and Thrombosis (1) · Eye Diseases (1) · Eye Diseases, Hereditary (1) · Retinal Diseases (1) · Thrombosis (1) · Vascular Diseases (1) · Venous Thrombosis (1)
Ranibizumab (2) · KH902 fusion protein (1) · aflibercept (1)
Cairo University (1) · David M. Brown, M.D. (1) · Wenbin Wei (1)
China (1) · Egypt (1) · United States (1)
David M Brown, MD (1) · Wenbin Wei, MD (1)